Search

Your search keyword '"Simón-Sánchez, Javier"' showing total 201 results

Search Constraints

Start Over You searched for: Author "Simón-Sánchez, Javier" Remove constraint Author: "Simón-Sánchez, Javier"
201 results on '"Simón-Sánchez, Javier"'

Search Results

1. Assessment of the impact of a personalised nutrition intervention in impaired glucose regulation over 26 weeks: a randomised controlled trial

2. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

4. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

7. Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data

8. Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy

9. No genetic association between attention-deficit/hyperactivity disorder (ADHD) and Parkinson’s disease in nine ADHD candidate SNPs

10. Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease

12. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

13. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD

14. A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinsonʼs disease

15. Identification of candidate parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets

19. Investigation of Autosomal Genetic Sex Differences in Parkinson's Disease

20. Identification of sixteen novel candidate genes for late onset Parkinson's disease

22. A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release

23. Analysis of Genome-Wide Association Studies of Alzheimer Disease and of Parkinson Disease to Determine If These 2 Diseases Share a Common Genetic Risk

24. The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinsonʼs disease with a sexual dimorphism

25. Use of support vector machines for disease risk prediction in genome-wide association studies: Concerns and opportunities

26. Using genome-wide complex trait analysis to quantify ‘missing heritability’ in Parkinsonʼs disease

28. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions

33. The chromosome 9 ALS and FTD locus is probably derived from a single founder

34. The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight

35. No genetic association between attention-deficit/hyperactivity disorder (ADHD) and Parkinson's disease in nine ADHD candidate SNPs

36. The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight

37. The clinical, neuroanatomical, and neuropathologic phenotype of TBK1-associated frontotemporal dementia: A longitudinal case report

38. Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption

40. LRP10 in α-synucleinopathies

41. HPCA confirmed as a genetic cause of DYT2-like dystonia phenotype

42. NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases

43. Lack of evidence for a role of genetic variation in TMEM230 in the risk for Parkinson's disease in the Caucasian population

44. Parkinson's disease age at onset genome-wide association study: Defining heritability, genetic loci, and α-synuclein mechanisms.

46. The clinical, neuroanatomical, and neuropathologic phenotype of TBK1 ‐associated frontotemporal dementia: A longitudinal case report

47. Comprehensive promoter level expression quantitative trait loci analysis of the human frontal lobe

48. C9orf72 is differentially expressed in the central nervous system and myeloid cells and consistently reduced in C9orf72, MAPT and GRN mutation carriers

50. Genetic comorbidities in Parkinson's disease

Catalog

Books, media, physical & digital resources